Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

Systemic treatment with the active transcription inhibitor lurbinectedin aims at inducing tumor cell death in hyperproliferative neoplasms. Here we show that cell death induced by lurbinectedin reinstates and enhances systemic anticancer immune responses. Lurbinectedin treatment showed traits of imm...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wei Xie, Sabrina Forveille, Kristina Iribarren, Allan Sauvat, Laura Senovilla, Yan Wang, Juliette Humeau, Maria Perez-Lanzon, Heng Zhou, Juan F. Martínez-Leal, Guido Kroemer, Oliver Kepp
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2019-11-01
Edice:	OncoImmunology
Témata:	anticancer immunity immunogenic cell death checkpoint blockade tumor clearance
On-line přístup:	http://dx.doi.org/10.1080/2162402X.2019.1656502
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!